The multi-award-winning FPM Annual Symposium has gone from strength to strength over recent years and this time we are delighted to be using the prestigious Royal Society – a celebrated conference space in the heart of London.

Pharmaceutical medicine is a truly global discipline and pharmaceutical physicians play a key role in driving innovation and raising standards of care around the world.

For this year’s FPM Annual Symposium we’re joined by leaders from across the global life sciences community – pharmaceutical physicians, scientists, regulators, patients and policymakers – to explore the specialty’s contribution to science and practice in a range of endeavours. They include the harnessing of AI which, together with other novel technologies such as precision medicine and genomics, has enormous potential for gathering evidence, targeting treatments, and enhancing the patient experience, but also bring new risks and challenges.

We will explore how health systems around the world must adapt as chronic physical and mental health issues become more prevalent, reflecting upon pharmaceutical medicine’s vital role in understanding impacts and developing mitigations. We look at pioneering treatments to control the effect of infectious diseases on populations, and explore issues of equity and access, and the role of patients in co-designing the future of healthcare, all the time equipping delegates with relevant tools and knowledge.

Join us at this year’s event to hear from outstanding speakers, meet with our event partners and sponsors, and network and exchange ideas with peers.

For those who cannot attend in person, we are offering an online attendance option. All plenary keynote sessions/panels and deep dive sessions taking place in the main auditorium will be live-streamed. They will also be made available to view after the event, via the FPM On Demand platform.

FPM
Annual
Symposium

FPM
Annual
Symposium

Who is this event for?
This event is designed for anyone with a professional interest in pharmaceutical medicine, including all healthcare professionals, pharmaceutical physicians, doctors working in other specialties, research scientists, patients, and policymakers.